BlackRock Group’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

BlackRock Group’s Portfolio CBPO Stock Details CBPO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$22.1M	Buy	205,356 +29,094	+17%	+$3.4M	0.01%	762
2016 Q3	$21.9M	Sell	176,262 -75,171	-30%	-$8.87M	0.01%	760
2016 Q2	$26.7M	Sell	251,433 -89,420	-26%	-$10.4M	0.01%	717
2016 Q1	$39M	Sell	340,853 -32,677	-9%	-$3.83M	0.02%	636
2015 Q4	$53.2M	Buy	373,530 +78,261	+27%	+$9.03M	0.03%	564
2015 Q3	$26.5M	Buy	295,269 +52,558	+22%	+$5.55M	0.02%	709
2015 Q2	$28M	Buy	242,711 +236,549	+3,839%	+$24.9M	0.02%	732
2015 Q1	$589K	Sell	6,162 -6,489	-51%	-$485K	﹤0.01%	2125
2014 Q4	$851K	Sell	12,651 -5,646	-31%	-$350K	﹤0.01%	1976
2014 Q3	$987K	Buy	+18,297	New	+$901K	﹤0.01%	1792
2013 Q4	–	Sell	-7,230	Closed	-$211K	–	2861
2013 Q3	$211K	Buy	+7,230	New	+$180K	﹤0.01%	2470

Other funds holding CBPO

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $299B AUM 28.69% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BlackRock Group's CBPO Position: Q4 2016 in Review

BlackRock Group increased its China Biologic Products Holdings, Inc. (CBPO) stake by 17% in Q4 2016, buying an estimated $3.4M and bringing the position to 205,356 shares worth $22.1M. The position accounts for 0.01% of the portfolio, ranked #762.

BlackRock Group first reported a position in CBPO in Q3 2013 and has held it in 11 quarters since. The position peaked at $53.2M in Q4 2015. 143 funds tracked by Wall St. Rank hold CBPO as of Q4 2016.

BlackRock Group held 205,356 shares of China Biologic Products Holdings, Inc. worth $22.1M as of Q4 2016.
BlackRock Group bought 29,094 China Biologic Products Holdings, Inc. shares in Q4 2016, an estimated $3.4M.
China Biologic Products Holdings, Inc. made up 0.01% of BlackRock Group's portfolio in Q4 2016, its #762 holding.
BlackRock Group first reported a position in China Biologic Products Holdings, Inc. in Q3 2013 and has held it in 11 quarters since.
BlackRock Group's China Biologic Products Holdings, Inc. position peaked at $53.2M in Q4 2015.
143 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.